Trial intelligence / Profile preview

Dexamethasone in Emergency Laparotomy (AHA STEROID TRIAL)

NCT04791566Phase 4Completed

Start
Mar 2021
Primary completion
Oct 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexamethasone in intestinal obstruction and gastrointestinal perforation (GP) (4 arms). Primary endpoint: C-reactive protein at 24 hours. Started Mar 2021; status: completed.

02

Drugs

dexamethasone
03

Conditions

intestinal obstructiongastrointestinal perforation (GP)

Beyond the preview

Go deeper on NCT04791566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04791566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call